CARDIFF ONCOLOGY INC's ticker is CRDF and the CUSIP is 14147L108. A total of 96 filers reported holding CARDIFF ONCOLOGY INC in Q3 2021. The put-call ratio across all filers is 1.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $160 | -5.3% | 115 | 0.0% | 0.00% | – |
| Q2 2023 | $169 | -11.1% | 115 | 0.0% | 0.00% | – |
| Q1 2023 | $190 | +18.0% | 115 | 0.0% | 0.00% | – |
| Q4 2022 | $161 | – | 115 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | -100.0% | 115 | -86.2% | 0.00% | -100.0% |
| Q2 2022 | $2,000 | 0.0% | 831 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $2,000 | -60.0% | 831 | 0.0% | 0.00% | -50.0% |
| Q4 2021 | $5,000 | -16.7% | 831 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $6,000 | +500.0% | 831 | +748.0% | 0.00% | +300.0% |
| Q2 2021 | $1,000 | 0.0% | 98 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $1,000 | – | 98 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACT CAPITAL MANAGEMENT, LLC | 120,600 | $299,000 | 0.32% |
| Artal Group S.A. | 750,000 | $1,860,000 | 0.08% |
| Eventide Asset Management | 1,467,922 | $3,640,000 | 0.06% |
| Atom Investors LP | 33,798 | $84,000 | 0.04% |
| XTX Topco Ltd | 25,154 | $62,000 | 0.03% |
| ELKHORN PARTNERS LIMITED PARTNERSHIP | 19,000 | $47,000 | 0.02% |
| Engineers Gate Manager LP | 245,567 | $609,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 63,749 | $158,000 | 0.02% |
| KENNEDY CAPITAL MANAGEMENT LLC | 168,902 | $419,000 | 0.01% |
| Walleye Capital LLC | 123,305 | $306,000 | 0.01% |